Regarding progression-free survival (PFS), patients in the low-CALLY group tended to have shorter PFS durations; however, this difference did not reach statistical significance (HR: 1.15, 95% CI: 0.87–1.51, p = 0.326).
← all excerpts
The CALLY Index Is Associated with Overall Survival in Patients with De Novo Metastatic Gastric Adenocarcinoma.
1
0.3260
0.3260